3,4-Dihydroxyphenylacetic Acid
"3,4-Dihydroxyphenylacetic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A deaminated metabolite of LEVODOPA.
Below are MeSH descriptors whose meaning is more general than "3,4-Dihydroxyphenylacetic Acid".
Below are MeSH descriptors whose meaning is more specific than "3,4-Dihydroxyphenylacetic Acid".
This graph shows the total number of publications written about "3,4-Dihydroxyphenylacetic Acid" by people in Harvard Catalyst Profiles by year, and whether "3,4-Dihydroxyphenylacetic Acid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1998 | 0 | 3 | 3 |
2000 | 0 | 1 | 1 |
2001 | 1 | 4 | 5 |
2002 | 0 | 1 | 1 |
2004 | 1 | 2 | 3 |
2006 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2013 | 0 | 2 | 2 |
2019 | 0 | 1 | 1 |
Below are the most recent publications written about "3,4-Dihydroxyphenylacetic Acid" by people in Profiles.
-
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. Pharmacol Res Perspect. 2019 04; 7(2):e00470.
-
The rat with oxygen-induced retinopathy is myopic with low retinal dopamine. Invest Ophthalmol Vis Sci. 2013 Dec 19; 54(13):8275-84.
-
The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats. PLoS One. 2013; 8(8):e71593.
-
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. PLoS One. 2012; 7(2):e31522.
-
Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice. J Neurochem. 2012 Feb; 120(3):385-95.
-
Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol. 2011 Dec; 164(8):1949-58.
-
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proc Natl Acad Sci U S A. 2009 Dec 29; 106(52):22474-9.
-
Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci Lett. 2009 Sep 18; 461(2):155-8.
-
Augmentation of cocaine-sensitized dopamine release in the nucleus accumbens of adult mice following prenatal cocaine exposure. Dev Neurosci. 2009; 31(1-2):76-89.
-
Central dopamine deficiency in pure autonomic failure. Clin Auton Res. 2008 Apr; 18(2):58-65.